The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Biosimilar Growth Hormones Market Over The 2026–2030 Period?
The biosimilar growth hormones market size has seen significant expansion in recent years. It is projected to increase from $0.89 billion in 2025 to $0.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.1%. The historic period’s growth can be attributed to factors such as the high cost of branded growth hormone therapies, the increasing prevalence of growth hormone deficiency, a rise in pediatric growth disorder diagnoses, limited access to affordable treatment options, and a dependence on hospital-based administration.
The biosimilar growth hormones market is projected for significant expansion in the coming years. This market is anticipated to reach $1.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This projected growth is driven by several factors including the expiration of patents for branded growth hormones, an increase in biosimilar approvals, the wider availability of self-administration therapies, heightened awareness of growth disorders, and increased healthcare spending in developing regions. Key trends anticipated during this period involve the greater acceptance of affordable biosimilar growth hormones, a surge in demand for both pediatric and adult growth hormone treatments, a rising inclination towards subcutaneous self-administration, the growth of online pharmacies and specialized clinics, and enhanced regulatory approval for biosimilars.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp
What Key Factors Are Shaping The Biosimilar Growth Hormones Market Landscape?
The expansion of the global biosimilar growth hormone market is significantly influenced by the increasing number of children affected by growth hormone deficiency. This condition arises from damage to either the pituitary gland or hypothalamus, which can be attributed to an abnormal formation present before birth (congenital) or something that developed during or after birth (acquired). For example, in September 2023, Hormones Australia, a source from the Endocrine Society of Australia (ESA) – which serves as an Australia-based national authority for the treatment of endocrine related conditions and disease – reported that growth hormone deficiency is estimated to affect 2 to 3 out of every 10,000 people. Hence, the rising prevalence of growth deficiencies in children acts as a key driver for the biosimilar growth hormones industry.
How Is The Biosimilar Growth Hormones Market Segmented Across Different Segment Categories?
The biosimilar growth hormones market covered in this report is segmented –
1) By Route Of Administration: Subcutaneous, Intramuscular, Oral
2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics
Subsegments:
1) By Subcutaneous: Self-administration, Professional Administration
2) By Intramuscular: Pediatric Care, Adult Care
3) By Oral: Tablets, Capsules
What Trends Are Affecting The Direction Of The Biosimilar Growth Hormones Market?
Major companies operating in the biosimilar growth hormones market are creating innovative solutions, including human growth hormone, to improve the effectiveness and affordability of treatments for growth hormone deficiencies. Growth hormone solutions refer to medical interventions or supplements designed to stimulate or replace human growth hormone (HGH) in the body, addressing growth deficiencies or anti-aging objectives. For instance, in June 2023, Pfizer Inc., a US-based pharmaceutical company, and OPKO Health Inc., a US-based healthcare company, secured US Food and Drug Administration (FDA) approval for NGENLA (somatrogon-ghla). This product is a once-weekly injectable human growth hormone treatment developed for pediatric patients experiencing growth hormone deficiency (GHD). This extended-release growth hormone therapy provides an alternative to daily injections, which can enhance patient adherence and convenience for both patients and their caregivers. The approval was granted based on clinical studies that established its efficacy and safety, marking a significant advancement in growth hormone therapies.
Which Organizations Play A Role In The Biosimilar Growth Hormones Market Landscape?
Major companies operating in the biosimilar growth hormones market are Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Dr. Reddy’s Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation
Get The Full Biosimilar Growth Hormones Market Report:
https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report
Which Region Represents The Largest Share Of The Biosimilar Growth Hormones Market?
North America was the largest region in the biosimilar growth hormone market in 2025. The Middle East is expected to be the fastest-growing region in the biosimilar growth hormones market report during the forecast period. The regions covered in the biosimilar growth hormones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Biosimilar Growth Hormones Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report
Browse Through More Reports Similar to the Global Biosimilar Growth Hormones Market 2026, By The Business Research Company
Hormonal Contraceptives Market Report 2026
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report
Parathyroid Hormones Market Report 2026
https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report
Biosimilar Hormone Market Report 2026
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model